Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BNIP3P41 stands for "BCL2 interacting protein 3 pseudogene 41," which is a human gene classified as a pseudogene—a DNA sequence related to the BNIP3 family members but does not produce a functional protein[1][2]. Pseudogenes are remnants of once-functional genes that have lost their protein-coding ability due to mutations. While the functional BNIP3 and BNIP3L (NIX) proteins are mitochondrial stress sensors involved in cell death, hypoxia response, and disease, BNIP3P41 itself does not encode any active protein and is not recognized as a therapeutic target[1][2]. There is no substantive data linking BNIP3P41 to biological function, disease role, or pharmacological intervention. If you require structured information for the functional BNIP3 protein, which is a biologically active mitochondrial BH3-only protein involved in apoptosis and autophagy, please specify; BNIP3P41 itself is not suitable for therapeutic targeting or molecular pharmacology[1][2].
None applicable for BNIP3P41 (see above)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on BCL2 interacting protein 3 pseudogene 41 (BNIP3P41).